Cargando…
Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia
PURPOSE: This study aims to evaluate the influence of genetic polymorphisms of CYP2D6, CYP3A5, ABCB1, and APOE genes and nongenetic factors on steady-state plasma concentrations (Cpss) of donepezil and therapeutic outcomes in Thai patients with Alzheimer’s disease (AD) and vascular dementia (VAD). P...
Autores principales: | Yaowaluk, Thitipon, Senanarong, Vorapun, Limwongse, Chanin, Boonprasert, Rasda, Kijsanayotin, Pornpimol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732559/ https://www.ncbi.nlm.nih.gov/pubmed/31564952 http://dx.doi.org/10.2147/PGPM.S211259 |
Ejemplares similares
-
Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2018) -
Pathogenic PSEN1 Glu184Gly Mutation in a Family from Thailand with Probable Autosomal Dominant Early Onset Alzheimer’s Disease
por: Senanarong, Vorapun, et al.
Publicado: (2020) -
Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics
por: Cacabelos, Ramón, et al.
Publicado: (2012) -
Influence of the rs1080985 Single Nucleotide Polymorphism of the CYP2D6 Gene and APOE Polymorphism on the Response to Donepezil Treatment in Patients with Alzheimer's Disease in China
por: Liu, Mengyuan, et al.
Publicado: (2014) -
The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in
the MENA Region: A Systematic Review
por: Ali, Zainab, et al.
Publicado: (2019)